N/A N=15 Weight Loss Intervention for Individuals With Lower Extremity Amputation
Lower Extremity Amputation
Primary: Number of Individuals That Were Randomized of Those Contacted (Feasibility) — 15 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=26 Safety and Efficacy of Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV-1 Reservoir
HIV I Infection
Primary: Part A: Number of Participants With Adverse Events (AE) and Serious Adverse Events (SAE) — 6; 6; 1; 6 participants
Phase 3 N=2,463 Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women
Osteoporosis · Postmenopausal Osteoporosis
Primary: Number of Participants With New Vertebral Fractures at 18 Months — 30; 4; 6 participants — p=<0.0001
Phase 2 N=44 Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes
Type 2 Diabetes Mellitus
Primary: Adjusted Mean Percent Change From Baseline in Insulin Sensitivity at Week 12 (Last Observation Carried Forward [LOCF]) — -9.99; 7.98 % Change of Baseline Insulin…
Phase 4 N=171 A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS).
Benign Prostatic Hyperplasia
Primary: Percentage of Participants Preferring Combination Therapy Over Alpha Blocker Alone on the Treatment Preference Questionnaire (TPQ) — 44.0; 68.3; 56.0; 31.7 percentage of…
N/A N=81 Pulsed Radiofrequency vs. Steroid Injections for Occipital Neuralgia
Occipital Neuralgia
Primary: Change in Average Occipital Pain 6 Weeks After the Start of Treatment — 3.068; 3.738 units on a scale
N/A N=26 Volume Guarantee Ventilation in Preterm Infants With Frequent Episodes of Hypoxemia
Episodic Hypoxemia in Mechanically Ventilated Preterm Infants
Primary: Percentage of Time Spent With Arterial Oxygen Saturation < 75% — 5; 4.4 % of time — p=0.44
Phase 3 N=540 A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Treatment of Physician's Choice in Subjects With Advanced Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer (NSCLC)
Primary: Overall Survival (OS) — 9.5; 9.5 months — p=0.1343
N/A N=634 Neutrophil-to-Lymphocyte Ratio in Bladder Cancer: A Secondary Biomarker Analysis of SWOG 8710
Bladder Cancer
Primary: Overall Survival — 58; 58 participants
Phase 3 N=280 Study of Ibrutinib (a Bruton's Tyrosine Kinase Inhibitor), Versus Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy
Mantle Cell Lymphoma
Primary: Progression Free Survival (PFS) — 15.6; 6.2 Months — p=< 0.0001
Phase 3 N=9,340 Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
Diabetes · Diabetes Mellitus, Type 2
Primary: Time From Randomisation to First Occurrence of Cardiovascular Death, Non-fatal Myocardial Infarction, or Non-fatal Stroke (a Composite Cardiovascular Outcome) — 13.0…
N/A N=239 Effect of Prevnar 13 on Ear Infections in Children
Otitis Media
Primary: Percentage of Middle Ear Fluid (MEF) Samples With Positive Results for Streptococcus Pneumoniae Serotypes 1, 3, 5, 6A, 7F, or 19A in Participants With Acute Otitis Media…
Phase 3 N=168 Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACW at 24 to 30 m in Primed Subjects
Infections, Meningococcal
Primary: Number of Subjects With Serum Bactericidal Assay Against N. Meningitidis Serogroups A, C Using Rabbit Complement (rSBA-MenA,C) Antibodies — 65; 59; 30; 66 Subjects
N/A N=79 Improving Cesarean Section Experience Through Hypnotherapy
Cesarean Section · Pain · Anxiety
Primary: Wellbeing Measured Using a Comfort Scale — 6.7; 8.0 units on a scale
Phase 2 N=171 A Four-Week Multicenter Study Evaluating the Safety and Efficacy of Gefapixant (AF-219/MK-7264) in Subjects With Osteoarthritis of the Knee
Osteoarthritis of the Knee
Primary: The Primary Efficacy Endpoint of This Study is the Weekly Average Daily NPRS (Average Pain) — 5.3; 4.9 units on a scale